Update
$EyePoint Pharmaceuticals (EYPT.US)$ EyePoint's DURAVYU Shows Results for Diabetic Macular Edema, Improving Vision and Anatomy in Early Trial Data! Favorable Safety Profile Continues With No Duravyu-Related Ocular or Systemic Saes to Date
Benzinga· 2 mins ago
Benzinga· 2 mins ago
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment